THZ2 (CDK7-IN-1), an analog of THZ1, is a potent and selective CDK7 inhibitor(IC50:13.9 nM),with the potential to treat Triple-negative breast cancer (TNBC).
Molecular Weight:
566.05
Purity:
98.00%
CAS Number:
[1604810-84-5]
Formula:
C31H28ClN7O2
Target:
CDK
T7296
* VAT and and shipping costs not included. Errors and price changes excepted